The future of blood-based biomarkers for Alzheimer’s disease

Treatment of Alzheimer’s disease (AD) is significantly hampered by the lack of easily accessible biomarkers that can detect disease presence and predict disease risk reliably. Fluid biomarkers of AD currently provide indications of disease stage; however, they are not robust predictors of disease pr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Henriksen, Kim, O’Bryant, Sid E., Hampel, Harald, Trojanowski, John Q., Montine, Thomas J., Jeromin, Andreas, Blennow, Kaj, Lönneborg, Anders, Wyss-Coray, Tony, Soares, Holly, Bazenet, Chantal, Sjögren, Magnus, Hu, William, Lovestone, Simon, Karsdal, Morten A., Weiner, Michael W.
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4128378/
https://ncbi.nlm.nih.gov/pubmed/23850333
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jalz.2013.01.013
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados